Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahmet Guner

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Mycoses|June 4, 2021
Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patientsBircan Kayaaslan, Fatma Eser, Ayşe Kaya Kalem, et al.
European Journal of Gastroenterology & Hepatology|September 22, 2011
Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infectionRahmet Guner, Mustafa Karahocagil, Mehmet Buyukberber, et al.
Human Vaccines & Immunotherapeutics|June 26, 2024
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccinesMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
Mycoses|February 14, 2022
Incidence and risk factors for COVID-19 associated candidemia (CAC) in ICU patientsBircan Kayaaslan, Ayşe Kaya Kalem, Dilek Asilturk, et al.
Infectious Diseases and Therapy|January 28, 2026
Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label StudyGhassan S Dbaibo, Ismail Balik, İrem Akdemir, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
A New Laboratory Tool for COVID-19 Severity Prediction, CENIL ScoreElif Mukime Saricaoglu, Belgin Coskun, Muge Ayhan, et al.
Vaccines|November 11, 2022
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III TrialMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 16, 2025
Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3Sibel Yıldız Kaya, Behice Kurtaran, Nefise Öztoprak Çuvalcı, et al.
Scientific Reports|December 23, 2022
Surveillance of hemodialysis related infections: a prospective multicenter studyImran Hasanoglu, Rahmet Guner, Suzan Sahin, et al.
Annals of Saudi Medicine|May 30, 2016
Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter studyGul R Yilmaz, Murat Dizbay, Tumer Guven, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Mycoses|June 4, 2021
Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patientsBircan Kayaaslan, Fatma Eser, Ayşe Kaya Kalem, et al.
European Journal of Gastroenterology & Hepatology|September 22, 2011
Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infectionRahmet Guner, Mustafa Karahocagil, Mehmet Buyukberber, et al.
Human Vaccines & Immunotherapeutics|June 26, 2024
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccinesMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
Mycoses|February 14, 2022
Incidence and risk factors for COVID-19 associated candidemia (CAC) in ICU patientsBircan Kayaaslan, Ayşe Kaya Kalem, Dilek Asilturk, et al.
Infectious Diseases and Therapy|January 28, 2026
Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label StudyGhassan S Dbaibo, Ismail Balik, İrem Akdemir, et al.
Diagnostics (Basel, Switzerland)|November 27, 2024
A New Laboratory Tool for COVID-19 Severity Prediction, CENIL ScoreElif Mukime Saricaoglu, Belgin Coskun, Muge Ayhan, et al.
Vaccines|November 11, 2022
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III TrialMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 16, 2025
Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3Sibel Yıldız Kaya, Behice Kurtaran, Nefise Öztoprak Çuvalcı, et al.
Scientific Reports|December 23, 2022
Surveillance of hemodialysis related infections: a prospective multicenter studyImran Hasanoglu, Rahmet Guner, Suzan Sahin, et al.
Annals of Saudi Medicine|May 30, 2016
Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter studyGul R Yilmaz, Murat Dizbay, Tumer Guven, et al.
Pageof 7